Skip to: Content
Skip to: Site Navigation
Skip to: Search
SUNDAY, NOVEMBER 22, 2009
| Subscribe to Newser's RSS feeds RSS | Follow Newser on Twitter Twitter

NEWS ABOUT: Dysport

Dysport stories: 1 news summaries

Longer-Lasting Botox Rival Nears US Approval

Reloxin's makers claim it lasts longer

Apr 2, 09 8:25 AM CDT
(Newser) - After a 7-year run as the only show in town, Botox could soon face some competition. Awaiting FDA approval, Reloxin—the US version of a French product called Dysport—is being marketed as a quicker and longer-lasting treatment for botulinum toxin fans. But doctors themselves are confused about what differences,... More »

MORE ABOUT:
cosmetic surgery • Botox • pharmaceutical • Food and Drug Administration • Dysport • Reloxin

1 Story


from our news partners